E 2020

Known as: E-2020, E2020 
 

Topic mentions per year

Topic mentions per year

1992-2017
051019922017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
OBJECTIVE The authors evaluated the effects of donepezil (10 mg/day) versus placebo on brain glucose metabolism. METHODS This… (More)
Is this relevant?
2000
2000
Donepezil hydrochloride ((+/-)-2-[(1-benzylpiperidin-4-yl)methyl]-5, 6-dimethoxy-indan-1-one monohydrochloride: E2020: donepezil… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
BACKGROUND Several cholinesterase inhibitors are either being utilized for symptomatic treatment of Alzheimer's disease or are in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
1998
1998
The effects of (-)-huperzine A ((5R,9R,11E)-5-amino-11-ethylidene-5,6,9,10-tetrahydro-7-methyl-5, 9-methanocycloocta[b]pyridin-2… (More)
Is this relevant?
1998
1998
Comparative effects of cholinesterase inhibitors (ChEI) huperzine A with E2020 and tacrine on the radial maze performance in… (More)
Is this relevant?
1996
1996
The potential of heptylphysostigmine tartrate (pyrrolo [2,3b] indol-5-ol, 3,3a,8,8a-hexahydro-1,3a,8-trimethylheptylcarbamate… (More)
Is this relevant?
1996
1996
The effects of huperzine A on memory impairments induced by scopolamine were evaluated using a radial maze task and inhibition of… (More)
Is this relevant?
1996
1996
The phase III drug-candidate, E2020, developed for treatment of Alzheimer's disease, and possibly other demenitas, and its… (More)
Is this relevant?
1995
1995
Following the discovery of a new series of anti-acetylcholinesterase (anti-AChE) inhibitors such as 1-benzyl-4-[2-(N-benzoylamino… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
1993
1993
E2020 is a new cholinesterase inhibitor with a novel chemical structure, which is under clinical investigation for use in… (More)
Is this relevant?